[The role of urogenital trichomonas in the genesis of changes in the portio epithelium].
D000935:Antifungal Agents / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D000994:Antitrichomonal Agents / Q000009:adverse effects; D002584:Cervix Uteri / Q000473:pathology*; D004848:Epithelium / Q000473:pathology; D005260:Female; D006590:Hexetidine / Q000009:adverse effects; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects; D014247:Trichomonas Vaginitis / Q000188:drug therapy / Q000473:pathology*; D002577:Uterine Cervical Diseases / Q000209:etiology*
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D011743:Pyrimidines; D008795:Metronidazole; D006590:Hexetidine
Die Rolle der urogenitalen Trichomonase in der Entstehung von Veränderungen des Portioepithel.